LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

Search

IQVIA Holdings Inc

Closed

SectorHealthcare

164.36 -1.26

Overview

Share price change

24h

Current

Min

162.56

Max

166.8

Key metrics

By Trading Economics

Income

1B

1.4B

Sales

264M

4.4B

P/E

Sector Avg

21.266

110.024

Profit margin

31.187

Employees

93,000

EBITDA

266M

1B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+38.51% upside

Dividends

By Dow Jones

Next Earnings

5 May 2026

Market Stats

By TradingEconomics

Market Cap

-11B

28B

Previous open

165.62

Previous close

164.36

News Sentiment

By Acuity

50%

50%

165 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

IQVIA Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

17 Feb 2026, 23:44 UTC

Hot Stocks

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 Feb 2026, 23:20 UTC

Earnings

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 Feb 2026, 22:57 UTC

Earnings

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 Feb 2026, 21:59 UTC

Earnings

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 Feb 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 Feb 2026, 23:54 UTC

Market Talk

Global Equities Roundup: Market Talk

17 Feb 2026, 23:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 Feb 2026, 23:45 UTC

Market Talk

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 Feb 2026, 23:19 UTC

Earnings

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 Feb 2026, 23:15 UTC

Earnings

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 Feb 2026, 22:58 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 Feb 2026, 22:58 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 Feb 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 Feb 2026, 22:50 UTC

Acquisitions, Mergers, Takeovers

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 Feb 2026, 22:44 UTC

Earnings

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 Feb 2026, 22:42 UTC

Earnings

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 Feb 2026, 22:36 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 Feb 2026, 22:36 UTC

Earnings

Santos Final Dividend 10.3 U.S. Cents/Security

17 Feb 2026, 22:36 UTC

Earnings

Santos FY Underlying Profit US$898 Million, Down 25%

17 Feb 2026, 22:35 UTC

Earnings

Santos FY Revenue US$4.94 Billion, Down 8%

17 Feb 2026, 22:35 UTC

Earnings

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 Feb 2026, 22:35 UTC

Acquisitions, Mergers, Takeovers

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 Feb 2026, 22:34 UTC

Earnings

Santos FY Net Profit US$818 Billion, Down 33%

17 Feb 2026, 22:02 UTC

Acquisitions, Mergers, Takeovers

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 Feb 2026, 21:50 UTC

Acquisitions, Mergers, Takeovers

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 Feb 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

17 Feb 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 Feb 2026, 21:49 UTC

Acquisitions, Mergers, Takeovers

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 Feb 2026, 21:48 UTC

Acquisitions, Mergers, Takeovers

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 Feb 2026, 21:48 UTC

Acquisitions, Mergers, Takeovers

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Peer Comparison

Price change

IQVIA Holdings Inc Forecast

Price Target

By TipRanks

38.51% upside

12 Months Forecast

Average 231.23 USD  38.51%

High 266 USD

Low 174 USD

Based on 16 Wall Street analysts offering 12 month price targets forIQVIA Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

12

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

150.68 / 153.45Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

165 / 351 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.
help-icon Live chat